Series: Our milestones

The results from the European EPIC have shaped our understanding of diet and cancer.

The START trials provided the evidence needed to change practice for women having radiotherapy to treat breast cancer.

The results of a breast cancer trial we helped fund allowed surgeons to move away from ‘radical’ mastectomies towards kinder, less invasive surgeries.

We go back to the 1950s to find out how one of our scientists helped transform the outlook for women with a rare cancer called choriocarcinoma.

Find out how an unexpected discovery by our scientists almost 2 decades ago is helping improve cancer diagnosis today.

We look at one of Cancer Research UK’s key trials, proving the drug anastrozole should be the gold standard for treating breast cancer in postmenopausal women.

We look back to the 1990s, and to our ‘first-in-man’ trial of prostate cancer drug abiraterone – a vital step in the drug’s development

In the latest in Our Milestones series, we look at how Cancer Research UK scientists helped develop one of the world’s most successful cancer drugs.

We go back to the 1980s, and the crucial discovery of a fundamental cancer gene by our researchers at The Institute of Cancer Research

In the latest Our Milestones series post, we look at the role we played in the advent of a 1970s cancer treatment revolution: combination chemotherapy.